NCT06230003View on ClinicalTrials.gov

Efficacy of Erector Spinae Plane (ESP) Block in Patients With Inflammatory Bowel Disease (IBD)

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

July 21, 2021

Primary Completion Date

December 17, 2024

Study Completion Date

March 1, 2025

Conditions
Opioid Use
Interventions
DRUG

Ropivacaine

Ultrasound guided ESP block either with the local anesthetic of 0.5% of Ropivicane 20 mL bilaterally (intervention group) or normal saline (control group) before surgery which will take 5-10 minutes in a 1:1 ratio.

DRUG

normal saline

Ultrasound guided bilateral ESP block either with normal saline

Trial Locations (1)

Unknown

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT06230003 - Efficacy of Erector Spinae Plane (ESP) Block in Patients With Inflammatory Bowel Disease (IBD) | Biotech Hunter | Biotech Hunter